当前位置:
X-MOL 学术
›
Proc. Natl. Acad. Sci. U.S.A.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction for Kudalkar et al., From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection [Correction]
Proceedings of the National Academy of Sciences of the United States of America ( IF 11.1 ) Pub Date : 2018-03-20 00:00:00 , DOI: 10.1073/pnas.1803199115 National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America ( IF 11.1 ) Pub Date : 2018-03-20 00:00:00 , DOI: 10.1073/pnas.1803199115 National Academy of Sciences
PHARMACOLOGY Correction for “From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection,” by Shalley N. Kudalkar, Jagadish …
中文翻译:
对Kudalkar等人的更正,从打击流行性感冒到对抗HIV-1感染的长效晚期临床前候选药物[更正]
药理学修正案: “从计算机模拟感染到对抗HIV-1感染的长效晚期临床前候选药物”,贾加迪什的Shalley N. Kudalkar……
更新日期:2018-03-21
中文翻译:
对Kudalkar等人的更正,从打击流行性感冒到对抗HIV-1感染的长效晚期临床前候选药物[更正]
药理学修正案: “从计算机模拟感染到对抗HIV-1感染的长效晚期临床前候选药物”,贾加迪什的Shalley N. Kudalkar……